TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 93 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2016. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,733,000 | -82.5% | 452,375 | -80.3% | 0.44% | -84.4% |
| Q2 2016 | $9,888,000 | -41.5% | 2,299,529 | -37.1% | 2.83% | -53.4% |
| Q1 2016 | $16,914,000 | -13.1% | 3,653,200 | +88.3% | 6.07% | -25.7% |
| Q4 2015 | $19,458,000 | +132.9% | 1,940,000 | +73.2% | 8.16% | +147.0% |
| Q3 2015 | $8,355,000 | – | 1,120,000 | – | 3.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 664,000 | $2,543,000 | 0.82% |
| GREAT POINT PARTNERS LLC | 452,375 | $1,733,000 | 0.44% |
| Clearline Capital LP | 267,915 | $1,026,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 300,000 | $1,149,000,000 | 0.18% |
| Rock Springs Capital Management LP | 662,500 | $2,537,000 | 0.16% |
| Eventide Asset Management | 600,000 | $2,298,000 | 0.14% |
| Granahan Investment Management | 657,496 | $2,518,000 | 0.08% |
| Candriam S.C.A. | 374,000 | $1,432,000 | 0.03% |
| Tekla Capital Management LLC | 192,322 | $737,000 | 0.03% |
| DOW CHEMICAL CO /DE/ | 65,000 | $249,000 | 0.02% |